Achieve Life Sciences, Inc. ACHV
Key Stats
- Today's Range
- $5.91 – $6.28
- 50-Day Range
- $4.43 – $7.11
- 52-Week Range
- $2.00 – $7.11
- Volume
- 1.30 million shs
- Average Volume
- 2.32 million shs
- Market Cap
- $634.43 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 59.41
- Price / Sales
- —
Short Interest
- Short Interest
- 0.13%
- Days to Cover
- 1.43
About Achieve Life Sciences, Inc.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.